Compliance with galantamine and vitamin E in Alzheimer's disease patients: The care trial.

被引：0
|
作者：
Feely, M
Amatniek, J
机构：
[1] Acad Unit Mol Vasc Med, Leeds, W Yorkshire, England
[2] Janssen Pharmaceut Prod, LP, Titusville, NJ USA
来源：
JOURNAL OF THE AMERICAN GERIATRICS SOCIETY | 2003年 / 51卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R592 [老年病学]; C [社会科学总论];
学科分类号：
03 ; 0303 ; 100203 ;
摘要：
P184
引用
收藏
页码：S105 / S106
页数：2
相关论文
共 50 条
  • [31] FDA approves galantamine for Alzheimer's disease
    不详
    AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2001, 58 (08) : 649 - 649
  • [32] Galantamine hydrobromide in a treatment of Alzheimer's disease
    Nikolova, G
    Yancheva, S
    Raychev, I
    Dobreva, D
    Traykov, L
    NEUROBIOLOGY OF AGING, 2002, 23 (01) : S96 - S96
  • [33] Response to galantamine in patients with vascular dementia or Alzheimer's disease plus cerebrovascular disease
    Erkinjuntti, T.
    Schwalen, S.
    Hammond, G.
    EUROPEAN JOURNAL OF NEUROLOGY, 2005, 12 : 189 - 189
  • [34] An update on using vitamin E in Alzheimer's disease
    Kontush, Anatol
    Schekatolina, Svetlana
    EXPERT OPINION ON DRUG DISCOVERY, 2008, 3 (02) : 261 - 271
  • [35] Vitamin E in neurodegenerative disorders - Alzheimer's disease
    Kontush, A
    Schekatolina, S
    VITAMIN E AND HEALTH, 2004, 1031 : 249 - 262
  • [36] The Effectiveness of Vitamin E Treatment in Alzheimer's Disease
    Lloret, Ana
    Esteve, Daniel
    Monllor, Paloma
    Cervera-Ferri, Ana
    Lloret, Angeles
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2019, 20 (04):
  • [37] Vitamin E in aging, dementia, and Alzheimer's disease
    Joshi, Yash B.
    Pratico, Domenico
    BIOFACTORS, 2012, 38 (02) : 90 - 97
  • [38] Emerging issues in the NIMH CATIE Alzheimer's disease effectiveness trial.
    Olin, J
    AMERICAN JOURNAL OF GERIATRIC PSYCHIATRY, 2002, 10 (02): : 45 - 46
  • [39] Efficacy of galantamine in probable vascular dementia and Alzheimer's disease combined with cerebrovascular disease: a randomised trial
    Erkinjuntti, T
    Kurz, A
    Gauthier, S
    Bullock, R
    Lilienfeld, S
    Damaraju, CV
    LANCET, 2002, 359 (9314): : 1283 - 1290
  • [40] Mortality-associated factors in patients with Alzheimer's disease treated with galantamine
    Lopez-Pousa, Secundino
    Garre Olmo, Josep
    Vilalta Franch, Joan
    Turon Estrada, Antoni
    Soler Cors, Olga
    Pericot Nierga, Imma
    MEDICINA CLINICA, 2006, 127 (06): : 206 - 210
12345